Final Report - TAMAHUD (Identification of early disease markers, novel pharmacologically tractable targets and small molecule phenotypic modulators in Huntington's Disease)
Project ID: 37472Funded under: FP6-IST
This is the final report for TAMAHUD which addressed key areas of HD patient need, namely the discovery and development of therapeutically meaningful novel targets and biomarkers. The document reports that following target validation activities, at least two targets are to be selected for assay development and primary screening activities, to identify drug-like compounds active on the target and efficacious against the HD mutation in cellular disease models.
Download application/zip (836697)
Record Number: 13290 / Last updated on: 2011-11-03